Literature DB >> 2482771

BPH epidemiology and risk factors.

P Ekman1.   

Abstract

Benign enlargement of the prostate gland is extremely common with increasing age. The incidence of gross enlargement of the gland has been reported as 40% in 70 year-old males. Microscopic foci can be found in 80%. The disease seems to be most common in blacks, Caucasians, and Jews, but less frequent in males from the Far East. Epidemiological studies are subject to many pitfalls, and the data have to be interpreted with great caution. The data from the World Health Organization indicate a marked drop in deaths from benign prostatic hyperplasia (BPH) during the last 12-year period. Increasing age and an intact androgen supply seem to be prerequisites for BPH development. Apart from that, no other risk factors have been identified uncontrovertedly.

Entities:  

Mesh:

Year:  1989        PMID: 2482771     DOI: 10.1002/pros.2990150505

Source DB:  PubMed          Journal:  Prostate Suppl        ISSN: 1050-5881


  7 in total

Review 1.  Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.

Authors:  L M Eri; K J Tveter
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

2.  The effects of transurethral resection of the prostate on morbidity and mortality in patients with nondialysis-requiring renal insufficiency.

Authors:  Alp Ozgur Akdemir; Cetin Volkan Oztekin; Omer Gokhan Doluoglu; Mehmet Karabakan; Ozgur Ugurlu; Mesut Cetinkaya
Journal:  Ther Adv Urol       Date:  2012-04

Review 3.  Flavonoid compounds in maintenance of prostate health and prevention and treatment of cancer.

Authors:  David M Brown; Graham E Kelly; Alan J Husband
Journal:  Mol Biotechnol       Date:  2005-07       Impact factor: 2.695

Review 4.  Role of prostate stem cells and treatment strategies in benign prostate hyperplasia.

Authors:  Kalyan J Gangavarapu; Peter F Jowdy; Barbara A Foster; Wendy J Huss
Journal:  Am J Clin Exp Urol       Date:  2022-06-15

Review 5.  Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia.

Authors:  D H Peters; E M Sorkin
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

Review 6.  Androgen receptor roles in the development of benign prostate hyperplasia.

Authors:  Kouji Izumi; Atsushi Mizokami; Wen-Jye Lin; Kuo-Pao Lai; Chawnshang Chang
Journal:  Am J Pathol       Date:  2013-04-06       Impact factor: 4.307

7.  Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia.

Authors:  Bong Kyun Park; Chang Won Kim; Jeong Eun Kwon; Manorma Negi; Yong Tae Koo; Sang Hun Lee; Dong Hyun Baek; Yoo Hun Noh; Se Chan Kang
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.